A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute describes a novel marker that might help doctors choose the least toxic, most effective treatment for many older patients with acute myeloid leukemia (AML).
from The Medical News http://ift.tt/1uL2Uo9
from The Medical News http://ift.tt/1uL2Uo9
No comments:
Post a Comment